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Gamma-secretase, which is responsible for the intramembranous cleavage of Alzheimer’s -amyloid pre-
cursor protein (APP), the signaling receptor Notch, and many other substrates, is a multiprotein complex
consisting of at least four components: presenilin (PS), nicastrin, APH-1, and PEN-2. Despite the fact that
PEN-2 is known to mediate endoproteolytic cleavage of full-length PS and APH-1 and nicastrin are required
for maintaining the stability of the complex, the detailed physiological function of each component remain
elusive. Unlike that of PS, the transcriptional regulation of PEN-2, APH-1, and nicastrin has not been
investigated. Here, we characterized the upstream regions of the human PEN-2 gene and identified a 238-bp
fragment located 353 bp upstream of the translational start codon as the key region necessary for the promoter
activity. Further analysis revealed a CREB binding site located in the 238-bp region that is essential for the
transcriptional activity of the PEN-2 promoter. Mutation of the CREB site abolished the transcriptional
activity of the PEN-2 promoter. Electrophoretic mobility shift assays and chromatin immunoprecipitation
analysis showed the binding of CREB to the PEN-2 promoter region both in vitro and in vivo. Activation of the
CREB transcriptional factor by forskolin dramatically promoted the expression of PEN-2 mRNA and protein,
whereas the other components of the -secretase complex remained unaffected. Forskolin treatment slightly
increases the secretion of soluble APP and A without affecting Notch cleavage. These results demonstrate
that expression of PEN-2 is regulated by CREB and suggest that the specific control of PEN-2 expression may
imply additional physiological functions uniquely assigned to PEN-2.
The -secretase complex is a high-molecular-weight complex
that consists of at least four components: presenilins (PS)
(including PS1 and PS2), nicastrin, APH-1 (anterior pharynx
defective 1), and PEN-2 (presenilin enhancer 2) (9, 18, 20).
The PS/-secretase complex controls proteolytic processing of
a number of type 1 transmembrane proteins, including the
amyloid precursor protein APP, which can be sequentially
cleaved by -secretase (BACE1) and the PS/-secretase com-
plex to generate heterogeneous -amyloid (A) species. Most
of the species are A40 and the more deleterious A42, which
are generally believed to cause Alzheimer’s disease (AD) (13,
16). The discovery of PS1 and PS2 as major pathogenic genes
for familial AD, in addition to mutations in the APP gene (8,
38), demonstrates the importance of PS/-secretase in AD
pathogenesis. Furthermore, the PS/-secretase complex also
cleaves other functionally important proteins, such as Notch
(10), E-cadherin (28), ErbB4 (31), CD44 (21), etc., suggesting
the involvement of PS/-secretase in a broad range of biolog-
ical activities. Interestingly, although knocking out PS (11),
nicastrin (24, 25), or APH-1 (27) in mice results in lethality and
abnormal embryonic phenotypes which resemble that of Notch
null mice (6, 17, 41), the phenotypes among different gene
knockouts are not identical, implying that each of these
-secretase components may have its own unique physiological
functions in addition to the -secretase activity.
Presenilins undergo endoproteolytic cleavage to generate an
amino-terminal fragment (NTF) and a carboxyl-terminal frag-
ment, which form functional PS heterodimers (42). The first
identified protein cofactor of PS in the -secretase complex,
nicastrin, is a type I transmembrane protein that can be highly
glycosylated on its ectodomain (47, 48). Two additional PS/-
secretase components, APH-1 and PEN-2, were identified
through genetic screening of Caenorhabditis elegans (12, 15).
There is only one PEN-2 homologue in mammals, whereas
there are two APH-1 homologues in mammals, identified as
APH-1a and APH-1b. Mammalian APH-1a has at least two
splice variants: APH-1aL and APH-1aS. Recent studies have
demonstrated that the four components of PS/-secretase reg-
ulate one another in a coordinate way; down-regulation/defi-
ciency of one given component typically results in a decrease in
the level of other components and/or a deficiency of their
trafficking/maturation (9, 18). In the absence of PS1, PEN-2 is
sequestered in the endoplasmic reticulum and not transported
to post-endoplasmic reticulum components, where the mature
-secretase complexes reside (44). PS deficiency also leads to
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destabilization of PEN-2 (26, 37), which is degraded via the
proteasome-mediated pathway (2, 7). On the other hand,
down-regulation of PEN-2 by small interfering RNA results in
an accumulation of full-length PS1 and a reduction of PS1
fragments, suggesting that PEN-2 is involved in PS1 endopro-
teolysis (26). Intracellular trafficking and maturation of nicas-
trin are also PS dependent: in the absence of PS, nicastrin fails
to reach the medial Golgi compartment and thus is incom-
pletely glycosylated (23). Moreover, nicastrin deficiency re-
duces the levels of APH-1, PEN-2, and PS1 fragments (24, 25,
49), while in APH-1a knockout cells, the levels of nicastrin,
PEN-2, and PS1 fragments are reduced (27).
Despite its broad biological importance, studies of transcrip-
tion regulation of the PS/-secretase components are largely
missing. Several studies have identified promoter regions of
presenilins, showing that PS1 transcription may be regulated
by the cyclic AMP-response element-binding protein (CREB)
(30), Ets factors, Sp1 (33), and/or possibly HIF-1a (1) and that
PS1 transcription regulation may be cell type specific (33).
However, to our knowledge there is no such report on tran-
scriptional regulation of PEN-2, APH-1, or nicastrin. In the
current study, we identify and characterize the promoter re-
gion of PEN-2 and demonstrate that transcription of PEN-2 is
regulated by CREB.
MATERIALS AND METHODS
Cell culture. HeLa cells, SH-SY5Y cells, and HEK 293T cells were cultured in
Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum.
All cells were maintained at 37°C in an incubator containing 5% CO2.
Cloning of the PEN-2 promoter and construction of chimeric luciferase re-
porter plasmids. PCR was performed to amplify the 5-flanking regions of the
PEN-2 gene by using human peripheral blood lymphocyte genomic DNA as the
template. The primers used to generate different promoter deletion plasmids
were as follows: forward, 5-CGACGCGTTGCCCCCAGGCCTGGTCCCTTA
CTC-3, 5-CGACGCGTAGAGAGTGAGGCATGAAGGTTG-3, 5-CGACG
CGTATAGGCGGGACATGGTGACGAC-3, 5-CGACGCGTGGCTGAAT
GTCGGCTTGTTGTG-3, 5-CGACGCGTAGGTGCAAAGACAAAGGTG
AAC-3, 5-CGACGCGTTTCTCACTTGTCCTTCTCAGTC-3, and 5-CGAC
GCGTCTCCAGGTCTGGCTGCTCTTAC-3; reverse, 5-CCCTCGAGCGCG
AGACGCCCCAGGTTTC-3, 5-CCCTCGAGATTGTAGTCTTCTTTGGGC
GAG-3, and 5-CCCTCGAGATGCGCTGTTAAAAGAACTCCTACCG-3.
Primers were designed to contain MluI or XhoI restriction sites so that the
resulting PCR-amplified fragments could be cloned into the multicloning sites
upstream of the luciferase reporter gene in the pGL3-enhancer expression vector
(Promega). Site-directed mutations were integrated into the PEN-2 promoter
fragments by overlapping PCR. The mutated fragments were then cloned into
vector pGL3-basic (Promega). To generate these mutants, two end primers,
5-CGACGCGTATAGGCGGGACATGGTGACGAC-3 (forward) and 5-CC
CTCGAGCGCGAGACGCCCCAGGTTTC-3 (reverse), were used in combi-
nation with various primers with mutations: AP-1mut1, 5-CGACGCGTATAG
GCGGGACATGGGTACGACGGC-3; AP-1mut2, 5-CTGCTCTTACGTACC
TTCCGTTG-3, and its reverse complementary sequence (RCS); HIF-1mut,
5-CAGCGCATGTGTGCAGTGTTGC-3, and its RCS; NF-ATmut1, 5-CGC
TCGGAATCGCCCCAGG-3, and its RCS; NF-AT&c-relmut, 5-GCTCGTG
AACGCCCCAGG-3, and its RCS; NF-ATmut2, 5-CCCTCGAGCGCGAGA
CGCCCCAGGTTTAACTGGAGATTG 3; CREBmut1, 5-CGACGCGTATA
GGCGGGACATGGTGACTACGGCCCCAG-3; CREBmut2, 5-CTGCTCTT
ATGTCACTTCCGTTG-3, and its RCS; c-relmut1, 5-CGACGCGTATAGG
CGGGACATGGTGACGACGGCCCCAGAAGGAGAG-3; c-relmut2, 5-GC
TCGGAAACGAACCAGGG-3, and its RCS; and ATF-6mut, 5-GAAACACC
GCCCCAAAACCCAG-3, and its RCS. Mutations are shown in boldface,
underlined type. The PEN-2 promoter fragment from bp 889 to bp 290 was
cut off from the 600-bp pGL3E plasmid by using MluI and XhoI and then linked
into pGL3-basic to generate a wild-type plasmid for the positive control.
Transfection and luciferase assay. HeLa cells were grown to approximately
90% confluence and transfected with 0.6 g of plasmid DNA on 24-well plates
with Lipofectamine 2000 (Invitrogen) following the manufacturer’s instructions.
In order to normalize the different transfection efficiencies of various luciferase
constructs, the phRL-SV40 plasmid (where SV40 is simian virus 40) containing
the Renilla luciferase gene was cotransfected into the cells in a molar ratio of 1:50
(phRL-SV40:pGL3). Cells were harvested 24 h (pGL3-enhancer chimeric plas-
mids) or 48 h (pGL3-basic chimeric plasmids) after transfection and lysed with
passive lysis buffer (Promega). Firefly luciferase activities and Renilla luciferase
activities were measured sequentially using a dual luciferase reporter assay sys-
tem (Promega) and a luminometer (Beckman).
5-RACE. Total RNA was extracted from healthy human liver with Trizol
reagent (Invitrogen). 5 rapid amplification of cDNA ends (RACE) was per-
formed using a BD Smart Race cDNA amplification kit (BD Bioscience). To
amplify the 5 untranslated region of PEN-2, a gene-specific primer located 77 bp
upstream of ATG, 5-GATCAGAACAACCACGCCCCAGGAGAGC-3, was
used. The PCR products were cloned into pGEM-T vector (Promega) and
sequenced with primer SP6.
Electrophoretic mobility shift assay. HeLa nuclear extracts were prepared
using a nuclear extract kit (Activemotif). Oligonucleotides were synthesized and
annealed with their respective reverse complements to generate double-stranded
oligonucleotides, which include CREBwt (where wt is wild type), containing a
putative CREB binding site corresponding to the PEN-2 promoter from bp213
to bp 187 (5-GCTGCTCTTACGTCACTTCCGTTGCTT-3); CREBmut,
with a C3T mutation at bp 203 (boldface and underlined), (5-GCTGCTCT
TATGTCACTTCCGTTGCTT-3); CREB consensus sequence (Promega) (5-
AGAGATTGCCTGACGTCAGAGAGCTAG-3); AP4, as described in refer-
ence 3 (5-CACCCGGTCAGCTGGCCTACACC-3); HIF-1, as described in
reference 5, (5-ACCGGCCCTACGTGCTGTCTCAC-3); and SP1 (Promega)
(5-ATTCGATCGGGGCGGGGGAGC-3). Double-stranded CREBwt and
CREB consensus sequences were end labeled with [-32P]ATP by T4 polynucle-
otide kinase and separated from unincorporated nucleotides by Microspin G-25
columns (Amersham Biosciences). 32P-labeled CREBwt probes (35 fmol) were
incubated with or without HeLa nuclear extracts (10 g) in gel shift binding
buffer containing 4% glycerol, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM dithio-
threitol, 50 mM NaCl, 10 mM Tris-HCl (pH 7.5), and 50 g/ml poly(dI-dC) ·
poly(dI-dC) at room temperature for 20 min. 32P-labeled CREB consensus
sequences incubated with HeLa nuclear extracts were used for the positive
control. For the competition assay, HeLa nuclear extracts were incubated with
1.75 pmol (50 excess) of unlabeled competition oligonucleotides for 10 min
prior to addition of 35 fmol labeled probes. The samples were analyzed by 4%
nondenaturing polyacrylamide gel electrophoresis (PAGE) and exposed to X-ray
film at 70°C.
ChIP analysis. Chromatin immunoprecipitation (ChIP) assays were per-
formed using SH-SY5Y cells, as previously described (39, 40). The following
primers were used: for human PEN-2 promoter, 5-TTTTACCCAAGCCCTCC
AGG-3 (forward) and 5-CTCCTACCGGGGAGTCTATG-3 (reverse); and
for human GAPDH (gene encoding glyceraldehyde-3-phosphate dehydrogenase)
exon 8 amplification, 5-ATCACTGCCACCCAGAAGACTGTGGA-3 (for-
ward) and 5-TCATACCAGGAAATGAGCTTGACAAA-3 (reverse).
Forskolin treatments. HEK 293T cells were treated with forskolin (Sigma)
dissolved in dimethyl sulfoxide at different dosages for the indicated times.
Northern blot hybridization. Total RNA was extracted from HEK 293T cells
after forskolin treatments by use of Trizol reagent (Invitrogen). Equal amounts
of RNA from differentially treated cells were run on formaldehyde gels and then
transferred to nylon membranes. For Northern blot hybridization, a PEN-2
fragment excised from a human PEN-2 construct (26) by PstI and BglII, which
contains the first 236 bp of the PEN-2 protein encoding sequence, 12 bp of the
pRK5 vector sequence, and a hemagglutinin tag encoding sequence, was used as
the probe. The probe for GAPDH was prepared by PCR amplification using
primers 5-GTCAGTGGTGGACCTGACCT-3 (forward) and 5-TGCTGTAG
CCAAATTCGTTG-3(reverse) and using cDNA from HEK 293T cells as the
template. Probes were 32P-labeled using a random primed DNA labeling kit
(Roche Molecular Biochemicals) and hybridized to Northern blots.
Immunoblot and antibodies. Cell lysates were resolved by 4 to 20% Tris-
glycine sodium dodecyl sulfate (SDS)-PAGE, and proteins were detected by
Western blotting using different antibodies as indicated. Rabbit anti-PEN-2
polyclonal antibody and anti-APH-1 polyclonal antibody were from Zymed.
Rabbit anti-PS1 NTF antibody Ab14 and rabbit antinicastrin antibody 716 were
developed in our lab (49). Mouse anti-phospho-CREB antibody was from Cell
Signaling Technology. Mouse anti-	-tubulin antibody was from Sigma. Mono-
clonal antibodies 6E10 and 4G8 (Signet Laboratories), which recognize amino
acids 1 to 17 and 17 to 24 of the human A peptide, respectively, were used to
detect soluble APP	 (sAPP	) and A.
sAPP, A, and Notch assays. HEK 293T cells were transiently transfected
with human APP or Notch 
E-myc constructs. After 48 h, the cells were equally
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split into six plates and treated with or without 10 M forskolin for 1, 2, or 4 h.
The conditioned media were assayed for sAPP	 by Western blotting with anti-
body 6E10. A was immunoprecipitated from conditioned media using 4G8 and
immunoblotted with antibody 6E10 as described in reference 45. Cell lysates
were immunoblotted with anti-myc antibody 9E10 (to visualize Notch and its
intracellular domain [NICD]). For assaying the nascent conversion of Notch to
NICD, cells were pulse-labeled with 500 Ci/ml [35S]methionine for 15 min and
then chased in the presence/absence of 10 M forskolin for 1, 2, or 4 h. Cell
lysates were immunoprecipitated with anti-myc antibody 9E10, followed by SDS-
PAGE analysis and autoradiography.
RESULTS
Cloning of promoter of the human PEN-2 gene. To study the
transcriptional regulation of PEN-2, we analyzed the genomic
DNA sequence of PEN-2 by using multiple-promoter predic-
tion software. The prediction results suggested that the tran-
scriptional initiation site is likely located at around 300 bp
upstream of the translation start codon ATG. Two potential
promoter regions together with their respective TATA boxes
are located within a 600-bp region which is about 300 bp
upstream of ATG. Therefore, we cloned and sequenced a
1,043-bp fragment of the 5-flanking region. This 1,043-bp frag-
ment includes the 600-bp region predicted as the potential
promoter, which ranges from bp 889 to bp 290 upstream of
PEN-2 translation start codon ATG (Fig. 1). A computer-
based transcription factor binding site search showed several
putative regulatory elements, including AP-1, CREB, c-rel,
ATF-6, NF-AT, and HIF-1 binding sites, within the 600-bp
region (Fig. 1).
To determine the transcription initiation site of the human
PEN-2 gene, a primer extension assay was carried out using an
antisense primer located 77 bp upstream of the first ATG and
using the cDNA reverse transcribed from liver RNA as a
template. This reaction generated a PCR product of approxi-
FIG. 1. Sequence features of the human PEN-2 gene promoter.
The 600-bp fragment of the 5-flanking region of the human PEN-2
gene is shown. The numbering was based on the translation start site,
defined as 1. The putative transcription factor binding sites are
underlined and in boldface. The major transcription initiation site is
indicated by an arrow. m1 to m10 denote each putative transcription
factor binding site that was mutated for the study shown in Fig. 3.
FIG. 2. Functional deletion analysis of the human PEN-2 gene
promoter. (A) Schematic diagram of the PEN-2 promoter constructs
consisting of a 5-flanking region with serial deletions cloned into the
promoterless vector pGL3-enhancer. The numbers represent the end-
points of each construct. The deletion plasmids were confirmed by
sequencing and restriction enzyme digestion, and the digested samples
were analyzed on a 1.5% agarose gel. The vector size is 5.06 kb, and the
sizes of pen-2 promoter deletion constructs range from 0.24 to 1.04 kb.
(B) The constructed plasmids were cotransfected into HeLa cells with
phRL-SV40, and luciferase activity was measured after 24 h with a
luminometer. Renilla luciferase activity expressed by phRL-SV40 was
used to normalize the transfection efficiency. The values represent
means  standard errors (n  4). *, P  0.05 versus pGL3-control; **,
P  0.001 versus pGL3-control (both by analysis of variance with the
post hoc Newman-Keuls test).
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mately 160 bp, which was cloned into pGEM-T vector and
sequenced. The results indicated that the major transcription
initiation site is located 302 bp upstream of the PEN-2 trans-
lation start codon (Fig. 1).
Identification of the minimal promoter and cis-acting regu-
latory region. To determine whether the 600-bp fragment con-
tains the promoter of the PEN-2 gene, we subcloned this frag-
ment into a promoterless luciferase plasmid, pGL3-enhancer
(Fig. 2A), and transfected it into HeLa cells. The luciferase
activity was assayed using a dual luciferase system and normal-
ized with cotransfected Renilla luciferase activity. As shown in
Fig. 2B, the luciferase activity in cells transfected with the
luciferase gene driven by an SV40 promoter (bar 1), which was
used as a positive control and defined as 100% for normaliza-
tion purposes, was approximately 120-fold higher than the neg-
ative control of cells transfected with empty pGL3-enhancer
vector (bar 15). The level of luciferase gene expression driven
by the 600-bp fragment was approximately 123.4%  7.3% of
the positive control (Fig. 2B, bar 4), suggesting that the 600-bp
fragment contains a functional promoter region of the human
PEN-2 gene. However, extension of the 600-bp fragment’s 5
end to either bp 1332 or bp 1182 dramatically reduced its
promoter activity (Fig. 2B, bars 2 and 3), implying a negative
regulatory element located in the region between bp 1182
and bp 889.
To further identify the minimal promoter region required
for PEN-2 gene expression, a series of luciferase reporter gene
plasmids with different deletions of the 600-bp fragments was
constructed (Fig. 2A). Although a small truncation of 85 bp
from the 5 end showed no effect on luciferase expression (Fig.
2B, bar 5), a large truncation of 178 bp from the 5 end
significantly reduced luciferase expression (Fig. 2B, bar 6) and
a larger truncation of 299 bp further reduced luciferase expres-
sion to the basal level (Fig. 2B, bar 7). However, a further
truncation of 76 bp from the 5 end of the 299-bp truncated
fragment rescued luciferase expression to some extent (Fig.
2B, bar 8). These data suggest a positive regulatory cis-acting
element existing between bp804 and bp590 and a negative
regulatory element existing within the region of bp 590 to bp
526. On the other hand, for each 5 deletion fragment with a
reduced luciferase expression level (422 bp and 301 bp), an
additional truncation of 27 bp or 63 bp from the 3 end rescued
luciferase expression to a level similar to that of the positive
control (Fig. 2B, bars 10 and 13 versus bar 6; bars 11 and 14
versus bar 7), suggesting a negative regulatory element located
between bp 290 and bp 317. Interestingly, although the
fragment with an 85-bp truncation from the 5 end had mini-
mal effect on gene expression (Fig. 2B, bar 5), an additional
truncation of 27 bp from its 3 end greatly impaired luciferase
expression (Fig. 2B, bar 9 versus bar 5), whereas a longer
truncation of 63 bp from its 3 end only marginally reduced
luciferase expression (Fig. 2B, bar 12 versus bar 5). Together,
analysis of the deletion plasmids demonstrated that a 238-bp
fragment from bp 590 to bp 353 possesses minimal pro-
moter properties and that the flanking regions contain several
positive and negative regulatory elements.
The human PEN-2 gene promoter contains CREB binding
sites. Sequence analysis revealed that the 600-bp fragment
FIG. 3. Mutation of the potential CREB binding site dramatically
reduced PEN-2 promoter transcription activity. HeLa cells were trans-
fected with wild-type plasmid (pGL3-basic inserted with the PEN-2
promoter 600-bp fragment), various mutant constructs, or pGL3-basic.
Relative luciferase activity was determined in triplicate, and data were
normalized to Renilla luciferase activity expressed by phRL-SV40.
Data represent means  standard errors. *, P  0.05 versus the wild
type by analysis of variance with the post-hoc Newman-Keuls test.
FIG. 4. Electrophoretic mobility shift assay for the PEN-2 gene
promoter. The gel shift assay was performed as described in Materials
and Methods. Lane 1, labeled CREBwt probe without nuclear extract.
Incubation of 32P-labeled CREBwt with HeLa nuclear extracts re-
tarded the migration rate of the labeled probe, which formed a new
shifted DNA-protein complex band (lane 3) at the same position as the
positive control (lane 2) formed by incubating the 32P-labeled CREB
consensus (Cons.) oligonucleotide probe () with HeLa nuclear ex-
tract. Competition assays were performed by further adding a 50-fold
molar excess of unlabeled competition oligonucleotides, consensus
CREB (lane 4), CREBwt (lane 5), CREBmut (lane 6), consensus SP1
(lane 7), HIF-1 (lane 8), or AP4 (lane 9).
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contains several potential transcriptional factor binding sites,
including two AP-1 binding consensuses, two NF-AT binding
consensuses, two c-rel binding consensuses, two CREB binding
consensuses, one ATF-6 consensus, and one HIF-1 consensus
(Fig. 1). To define the potential transcriptional factor for the
PEN-2 promoter, we mutated these potential transcriptional
factor binding sites individually or collectively. The mutated
fragments were cloned into pGL3-enhancer luciferase reporter
vector, followed by promoter activity analysis. The mutation of
AP-1 located at bp 506 to bp 500 resulted in a 60% reduc-
tion of the promoter activity compared to that of the wild-type
600-bp promoter fragment (Fig. 3, m2). Interestingly, when a
CREB binding site congregating to the AP-1 site located at bp
506 to bp 500 was mutated, the promoter activity of the
600-bp promoter was abolished (Fig. 3, m8). In contrast, mu-
tation of other potential transcriptional binding sites had little
effect on the promoter activity (Fig. 3). These results suggest
that CREB is a potential transcriptional factor regulating
PEN-2 transcription. Because the AP-1 and CREB sites gather
together, mutation of the AP-1 site may indeed also impact
CREB binding, thus resulting in the reduced promoter activity.
To further investigate the binding of CREB to the element
located at bp 506 to bp 500, we performed gel shift assays.
A 27-bp double-stranded oligonucleotide corresponding to the
PEN-2 promoter region from bp 515 to bp 489 was synthe-
sized and labeled as the probe. As shown in Fig. 4 (lane 3), a
protein-DNA complex was detected after incubation of the
probe with HeLa nuclear extracts. As a positive control, a
classic CREB binding oligonucleotide probe (see Materials
and Methods) was also shown to form a protein-DNA complex
that migrated at the same position as the PEN-2 CREB probe-
protein complex (Fig. 4, lane 2). Notably, the PEN-2 CREB
probe was able to form the protein-DNA complex even more
effectively than the classic CREB consensus probe. The com-
plex formation between PEN-2 CREB probe-protein was dra-
matically inhibited and completely abolished by competitive
binding of the CREB consensus (Fig. 4, lane 4) and the PEN-2
CREB probe (Fig. 4, lane 5), respectively. In contrast, the
PEN-2 CREB probe-protein complex formation was not af-
fected by competition from a PEN-2 CREB oligonucleotide
with a mutated CREB binding site or the consensus probes of
SP-1, HIF-1, and AP-4. The results indicate that the identified
PEN-2 CREB binding element is able to form a complex with
nuclear CREB protein in vitro.
To confirm the PEN-2 CREB element binding to CREB
transcriptional factor in vivo, we next performed chromatin
immunoprecipitation analysis. Human neuroblastoma SH-
SY5Y cells were cross-linked, followed by immunoprecipita-
tion with an anti-CREB antibody or an antitubulin antibody.
The precipitates were then PCR amplified with a pair of PEN-2
CREB-specific primers. The results showed that a specific frag-
FIG. 5. ChIP analysis of CREB binding to the PEN-2 promoter.
Cross-linked chromatin extracts from SH-SY5Y cells were immuno-
precipitated with either anti-CREB antibody or antitubulin antibody.
The PEN-2 promoter fragment covering bp 539 to bp 370 and a
DNA fragment from exon 8 of the human GAPDH gene were PCR
amplified from the immunoprecipitated and the input chromatin, re-
spectively. MW, molecular weight.
FIG. 6. Activation of CREB by forskolin stimulated the gene tran-
scription and protein expression of PEN-2. (A) HEK 293T cells were
treated with 10 M forskolin for 0, 60, or 120 min. Protein levels of
PEN-2 and p-CREB were assayed by Western blot analysis. 	-Tubulin
was used as the loading control. (B) Total RNAs were extracted from
forskolin-treated HEK 293T cells for Northern blot hybridization anal-
ysis. The mRNA levels of PEN-2 and GAPDH were quantified for
comparison of the ratios of PEN-2 over GAPDH. Data represent
averages of three separate experiments. *, P 0.01 compared to 0-min
treatment.
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ment was amplified from the cell lysates and the anti-CREB
antibody precipitates but not from the antitubulin precipitates
(Fig. 5, upper panel). In contrast, a GAPDH DNA fragment
was amplified only from the input lysates with a pair of specific
GAPDH primers (Fig. 5, lower panel). These results suggest
that the identified PEN-2 promoter is able to specifically bind
CREB in vivo.
Activation of CREB up-regulates PEN-2 expression. We
next examined the role of CREB on transcription and protein
expression of PEN-2 in vivo. It is well documented that fors-
kolin treatment increases the phosphorylation of the active
form of CREB (14, 22). In agreement with the previous re-
ports, we showed that the treatment of HEK 293T cells with 10
m forskolin resulted in increased phosphorylation of CREB
(Fig. 6A). Accordingly, transcription of PEN-2 was increased
about 1.8-fold after a 60-min treatment and 1.4-fold after a
120-min treatment compared to results for the control (Fig.
6B), suggesting that activation of CREB stimulates the tran-
scription of PEN-2. The slight decrease of PEN-2 transcription
after a 120-min forskolin treatment compared to that of a
60-min treatment was likely caused by reduced CREB sensi-
tivity to forskolin. Treatment of cells with 10 m forskolin for
60 or 120 min significantly increased the protein level of PEN-2
(Fig. 6A).
The stimulatory effect of forskolin on PEN-2 expression is
concentration dependent: the effect was shown to be maximal
at 3 M and saturated at 10 M, while 1 M showed minimal
effect. In contrast, the other three -secretase complex com-
ponents, presenlin-1, nicastrin, and APH-1, were not changed
by forskolin treatment at various concentrations (Fig. 7A).
Thus, activation of CREB specifically stimulates PEN-2 ex-
pression. Consistent with previous observations (29, 46), we
also demonstrated that treatment of cells with forskolin for 4 h
slightly increased the secretion of A (by 30%) and sAPP	 (by
40%), a nonamyloidogenic cleavage product of APP by the
	-secretase (Fig. 7B) (13, 16). However, forskolin treatment
failed to affect the steady-state levels of Notch to NICD. We
also found that forskolin treatment did not alter the de novo
proteolytic conversion, by the -secretase activity, of Notch to
NICD, as examined by a pulse-chase experiment paradigm
(Fig. 7B).
DISCUSSION
A deposition is one of the most important pathological
features in AD. Sequential proteolytic cleavages of APP by
-secretase and the PS/-secretase complex are essential for
A generation (13, 16). Dissecting -secretase and -secretase
complex components, including the mechanisms underlying
their transcriptional regulation, will be greatly important for
understanding AD pathogenesis. Furthermore, PS/-secretase
FIG. 7. Forskolin treatment increased PEN-2 protein expression
and the secretion of sAPP	 and A without affecting protein expres-
sion of other -secretase components and Notch cleavage. (A) HEK
293T cells were treated with 10 M forskolin for 60 min. The same
amounts of cell lysates were analyzed and immunoblotted with anti-
bodies against PEN-2, PS1 NTF, nicastrin, and APH-1. The levels of
phospho-CREB (p-CREB) and 	-tubulin were detected for the posi-
tive control and loading control, respectively. p-ATF, phospho-ATF.
(B) HEK 293T cells were transiently transfected with human APP695
or Notch 
E. After 48 h, the cells were equally split into six plates and
treated with or without 10 M forskolin for 1, 2, or 4 h. The condi-
tioned media were assayed for sAPP	 by immunoblotting with anti-
body 6E10 and for A by immunoprecipitation using antibody 4G8
followed by Western blot analysis using 6E10. Cell lysates were immu-
noblotted with anti-myc antibody 9E10 to detect steady-state levels of
Notch and NICD. Cells were also pulse-labeled with [35S]methionine
for 15 min and then chased in the presence/absence of 10 M forskolin
for 1, 2, or 4 h. Cell lysates were immunoprecipitated with anti-myc
antibody 9E10, followed by SDS-PAGE analysis and autoradiography.
Data represent means  standard deviations (n  3). *, P  0.04.
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is also involved in multiple physiological activities, such as the
Notch signal pathway (10, 21, 28, 31, 36, 43), making it a target
of extensive scrutiny from neurobiological to cancer and de-
velopment fields. In the present study, we identified a 600-bp
fragment upstream of the PEN-2 translational start codon as a
critical PEN-2 promoter region responsible for its transcrip-
tion. There are several potential transcriptional factor binding
sites within this PEN-2 promoter region. However, only a
CREB binding site is shown to be essential for PEN-2 tran-
scription regulation: mutation of this CREB site resulted in
abolishment of the 600-bp fragment’s transcriptional activity.
Furthermore, both electrophoretic mobility shift assays and
ChIP analysis demonstrated the binding of CREB to the
PEN-2 promoter both in vitro and in vivo. Finally, activation of
CREB by forskolin significantly potentiates expression of
PEN-2 at both mRNA and protein levels. Together, these
results demonstrate that expression of PEN-2 is regulated by
the CREB transcriptional factor.
It has previously been reported that the transcription of
-secretase (BACE1) is regulated by SP1 (4). Among the four
-secretase components, however, only the promoter of PS and
its transcriptional regulation have been studied so far (1, 30,
33, 34, 35). Pastorcic and Das (33) showed that Ets factors
were involved in regulation of PS1 and that Ets factors were
differentially utilized in human neuroblastoma SH-SY5Y and
SK-N-SH cells. There are potential HIF binding sites on PS1/
PS2 promoter regions. Hypoxia treatment potentiated PS1
gene expression in interleukin-1- and A42-treated human
neural cells (1), implying that HIF-1a may be involved in
stress-mediated PS transcriptional regulation. Interestingly,
Mitsuda et al. (30) identified a CREB binding site on the PS1
promoter region and showed that, by using N-methyl-D-aspar-
tate to activate CREB for 6 h, both PS1 transcription and
translation were up-regulated in SK-N-SH cells. In our exper-
iments, however, CREB activation by forskolin failed to stim-
ulate protein expression of PS1, APH-1 and nicastrin in HEK
293T cells. This apparent discrepancy may be attributed to the
use of the different cell types or the ways to activate CREB.
Excitotoxic stimulants such as N-methyl-D-aspartate likely rep-
resent a stress which causes multiple cellular responses. In
addition, another study showed that 12-O-tetradecanoylphor-
bol 13-acetate is able to activate transcription of the human
presenilin 1 gene and that point mutations eliminating the 6
CREB/AP1 motif did not affect the stimulation by 12-O-tetra-
decanoylphorbol 13-acetate (34).
In addition to the amyloidogenic cleavage pathway by - and
-secretase, APP also undergoes a nonamyloidogenic cleavage
by 	-secretase activity to release sAPP	 (13, 16). Consistent
with previous reports (29, 46), we found that treatment of cells
by forskolin for 4 h stimulated the secretion of both sAPP	 and
A. However, forskolin did not affect the processing of Notch
by -secretase (Fig. 7B). Our results have shown that CREB
activation up-regulated only PEN-2 but not PS1, nicastrin, or
APH-1, indicating that the -secretase activity, which requires
precise stoichiometric interaction among all four components,
is unlikely to be affected. Previous reports showed that activa-
tion of protein kinase A promotes trafficking of secretory ves-
icles, including APP-containing vesicles, from the trans-Golgi
network to the plasma membrane (32, 46). We hence speculate
that, rather than altering -secretase activity, forskolin treat-
ment specifically increases the trafficking and release of APP-
and A-containing vesicles without affecting those vesicles car-
rying Notch molecules. In contrast to up-regulation of PEN-2
by CREB/protein kinase A activation, it is conceivable that
inhibition of CREB activation may down-regulate PEN-2 ex-
pression and hence reduce -secretase activity and A gener-
ation. Given the broad spectrum of -secretase substrates,
however, whether down-regulation of PEN-2 by inhibiting
CREB activation may specifically reduce A processing with-
out affecting other substrates (such as Notch) awaits further
investigation.
In addition to the essential role of PS and its associated
proteins in -secretase activity, numerous reports have as-
signed other physiological functions to PS and its partners,
including roles in regulating protein trafficking, platelet-de-
rived growth factor signaling, calcium homeostasis, skeletal
development, neurite outgrowth, apoptosis, synaptic plasticity,
and tumorigenesis (19, 23, 36, 43). Although mice lacking PS1
(11), nicastrin (24, 25), or APH-1 (27) individually are embry-
onically lethal and show defects resembling those found in
Notch null embryos (6, 17, 41), these knockout models still
exhibit patterning defects that are not identical to each other.
In the present study, CREB activation stimulated by forskolin
promoted only PEN-2 expression but not expression of other
-secretase components, even though it has been reported that
the PS1 promoter region possesses a CREB binding site (30).
These results suggest that additional physiological functions
may be uniquely assigned to PEN-2 through the specific con-
trol of PEN-2 expression.
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